Correlation Between Foghorn Therapeutics and Sol Gel

Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Sol Gel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Sol Gel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Foghorn Therapeutics and Sol Gel Technologies, you can compare the effects of market volatilities on Foghorn Therapeutics and Sol Gel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Sol Gel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Sol Gel.

Diversification Opportunities for Foghorn Therapeutics and Sol Gel

0.37

Correlation Coefficient

Foghorn Therapeutics  Sol Gel

Weak diversification

The 3 months correlation between Foghorn and Sol is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Sol Gel Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sol Gel Technologies and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Sol Gel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sol Gel Technologies has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Sol Gel go up and down completely randomly.

Pair Corralation between Foghorn Therapeutics and Sol Gel

Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 8.31 times less return on investment than Sol Gel. But when comparing it to its historical volatility, Foghorn Therapeutics is 3.49 times less risky than Sol Gel. It trades about 0.02 of its potential returns per unit of risk. Sol Gel Technologies is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  755.00  in Sol Gel Technologies on May 1, 2025 and sell it today you would earn a total of  445.00  from holding Sol Gel Technologies or generate 58.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.65%
Values	Daily Returns

Foghorn Therapeutics  vs.  Sol Gel Technologies

Foghorn Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Foghorn Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Foghorn Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Sol Gel Technologies

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sol Gel Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Sol Gel disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Foghorn Therapeutics and Sol Gel

The main advantage of trading using opposite Foghorn Therapeutics and Sol Gel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Sol Gel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sol Gel will offset losses from the drop in Sol Gel's long position.

The idea behind Foghorn Therapeutics and Sol Gel Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.